163 related articles for article (PubMed ID: 15878716)
21. Endothelin receptor antagonism does not prevent the development of in vivo glyceryl trinitrate tolerance in the rat.
Ratz JD; Fraser AB; Rees-Milton KJ; Adams MA; Bennett BM
J Pharmacol Exp Ther; 2000 Nov; 295(2):578-85. PubMed ID: 11046091
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of glyceryl trinitrate-induced vasodilation. I. Relationship between drug biotransformation, tissue cyclic GMP elevation and relaxation of rabbit aorta.
Brien JF; McLaughlin BE; Kobus SM; Kawamoto JH; Nakatsu K; Marks GS
J Pharmacol Exp Ther; 1988 Jan; 244(1):322-7. PubMed ID: 2826771
[TBL] [Abstract][Full Text] [Related]
23. Novel S-nitrosothiols do not engender vascular tolerance and remain effective in glyceryl trinitrate-tolerant rat femoral arteries.
Miller MR; Megson IL; Roseberry MJ; Mazzei FA; Butler AR; Webb DJ
Eur J Pharmacol; 2000 Sep; 403(1-2):111-9. PubMed ID: 10969151
[TBL] [Abstract][Full Text] [Related]
24. Effect of in vitro organic nitrate tolerance on relaxation, cyclic GMP accumulation, and guanylate cyclase activation by glyceryl trinitrate and the enantiomers of isoidide dinitrate.
Bennett BM; Schröder H; Hayward LD; Waldman SA; Murad F
Circ Res; 1988 Oct; 63(4):693-701. PubMed ID: 2901920
[TBL] [Abstract][Full Text] [Related]
25. Vasorelaxing effect of S-nitrosocaptopril on dog coronary arteries: no cross-tolerance with nitroglycerin.
Matsumoto T; Takahashi M; Nakae I; Kinoshita M
J Pharmacol Exp Ther; 1995 Dec; 275(3):1247-53. PubMed ID: 8531088
[TBL] [Abstract][Full Text] [Related]
26. Nomega-hydroxy-L-arginine homologues and hydroxylamine as nitric oxide-dependent vasorelaxant agents.
Beranova P; Chalupsky K; Kleschyov AL; Schott C; Boucher JL; Mansuy D; Munzel T; Muller B; Stoclet JC
Eur J Pharmacol; 2005 Jun; 516(3):260-7. PubMed ID: 15964563
[TBL] [Abstract][Full Text] [Related]
27. S-nitrosothiols as vasodilators: implications regarding tolerance to nitric oxide-containing vasodilators.
Henry PJ; Drummer OH; Horowitz JD
Br J Pharmacol; 1989 Nov; 98(3):757-66. PubMed ID: 2511992
[TBL] [Abstract][Full Text] [Related]
28. YC-1 enhances the responsiveness of tolerant vascular smooth muscle to glyceryl trinitrate.
O'Reilly DA; McLaughlin BE; Marks GS; Brien JF; Nakatsu K
Can J Physiol Pharmacol; 2001 Jan; 79(1):43-8. PubMed ID: 11201500
[TBL] [Abstract][Full Text] [Related]
29. Targeted and persistent effects of NO mediated by S-nitrosation of tissue thiols in arteries with endothelial dysfunction.
Sarr M; Chataigneau M; Etienne-Selloum N; Diallo AS; Schott C; Geffard M; Stoclet JC; Schini-Kerth VB; Muller B
Nitric Oxide; 2007 Aug; 17(1):1-9. PubMed ID: 17566772
[TBL] [Abstract][Full Text] [Related]
30. The nitric oxide donor SIN-1 is free of tolerance and maintains its cyclic GMP stimulatory potency in nitrate-tolerant LLC-PK1 cells.
Hinz B; Schröder H
Pharm Res; 1999 May; 16(5):633-6. PubMed ID: 10350003
[TBL] [Abstract][Full Text] [Related]
31. Ursolic acid mediates the vasorelaxant activity of Lepechinia caulescens via NO release in isolated rat thoracic aorta.
Aguirre-Crespo F; Vergara-Galicia J; Villalobos-Molina R; Javier López-Guerrero J; Navarrete-Vázquez G; Estrada-Soto S
Life Sci; 2006 Aug; 79(11):1062-8. PubMed ID: 16630635
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of the biotransformation and pharmacological actions of glyceryl trinitrate by the flavoprotein inhibitor, diphenyleneiodonium sulfate.
McGuire JJ; Anderson DJ; Bennett BM
J Pharmacol Exp Ther; 1994 Nov; 271(2):708-14. PubMed ID: 7965786
[TBL] [Abstract][Full Text] [Related]
33. Impaired effect of salt loading on nitric oxide-mediated relaxation in aortas from stroke-prone spontaneously hypertensive rats.
Kagota S; Kubota Y; Nejime N; Nakamura K; Kunitomo M; Shinozuka K
Clin Exp Pharmacol Physiol; 2007; 34(1-2):48-54. PubMed ID: 17201735
[TBL] [Abstract][Full Text] [Related]
34. The effect of oxidative stress on endothelium-dependent and nitric oxide donor-induced relaxation: implications for nitrate tolerance.
Hanspal IS; Magid KS; Webb DJ; Megson IL
Nitric Oxide; 2002 May; 6(3):263-70. PubMed ID: 12009844
[TBL] [Abstract][Full Text] [Related]
35. A common pathway for nitric oxide release from NO-aspirin and glyceryl trinitrate.
Grosser N; Schröder H
Biochem Biophys Res Commun; 2000 Jul; 274(1):255-8. PubMed ID: 10903927
[TBL] [Abstract][Full Text] [Related]
36. Superoxide does not inhibit glyceryl trinitrate-rabbit aortic strip-mediated relaxation of rabbit Taenia coli. Evidence against a role for nitric oxide itself as the smooth muscle active drug metabolite?
Hussain AS; Brien JF; Marks GS; Nakatsu K
Drug Metab Dispos; 1996 Jul; 24(7):780-5. PubMed ID: 8818576
[TBL] [Abstract][Full Text] [Related]
37. Prevention of nitroglycerin tolerance in vitro by T0156, a selective phosphodiesterase type 5 inhibitor.
Liu CQ; Leung FP; Lee VW; Lau CW; Yao X; Lu L; Huang Y
Eur J Pharmacol; 2008 Aug; 590(1-3):250-4. PubMed ID: 18554583
[TBL] [Abstract][Full Text] [Related]
38. Nitrate tolerance is specific for nitric acid esters and its recovery requires an intact protein synthesis.
Hinz B; Schröder H
Biochem Biophys Res Commun; 1998 Nov; 252(1):232-5. PubMed ID: 9813175
[TBL] [Abstract][Full Text] [Related]
39. Biotransformation of glyceryl trinitrate occurs concurrently with relaxation of rabbit aorta.
Brien JF; McLaughlin BE; Breedon TH; Bennett BM; Nakatsu K; Marks GS
J Pharmacol Exp Ther; 1986 May; 237(2):608-14. PubMed ID: 3084761
[TBL] [Abstract][Full Text] [Related]
40. The role of lipoic acid in prevention of nitroglycerin tolerance.
Dudek M; Bednarski M; Bilska A; Iciek M; Sokołowska-Jezewicz M; Filipek B; Włodek L
Eur J Pharmacol; 2008 Sep; 591(1-3):203-10. PubMed ID: 18616939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]